Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Makers Gear Up For 2023-2024 COVID-19 Season With Subvariant Vaccines

Pfizer/BioNTech, Moderna, Novavax Work With Regulators

Aug 22 2023

• By Alaric DeArment

Drug makers are preparing for the 2023-2024 COVID-19 season • Source: Shutterstock

Related Content

Novavax Readying Multiple COVID-19 Vaccine Candidates To Ensure Fall Availability

Jun 01 2023

Novavax’s COVID-19 Shot Finally Authorized In US, But Could Miss Out Again On Bivalent Booster

Jul 15 2022

Related Companies

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Novavax, Inc.

Additional Topics

Vaccines Coronavirus COVID-19 Research & Development Infectious Diseases BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.